Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
This study has been completed.
Study NCT00004771 Information provided by Office of Rare Diseases (ORD)
First Received: February 24, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Spinal Muscular Atrophy
Amyotrophic Lateral Sclerosis
Spinobulbar Muscular Atrophy
Additional conditions recognized in this trial
Atrophy
Motor Neuron Disease
Muscular Atrophy
Muscular Atrophy, Spinal
Muscular Disorders, Atrophic
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neuromuscular Manifestations
Pathologic Processes
Pathological Conditions, Anatomical
Signs and Symptoms
Spinal Cord Diseases
Interventions listed in this trial
leuprolide
testosterone
Additional drug interventions recognized in this trial
Methyltestosterone
Testosterone 17 beta-cypionate
More general drug interventions related to this trial
Anabolic Agents
Androgens
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Fertility Agents
Fertility Agents, Female
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
National Center for Research Resources (NCRR)
Ohio State University
Back to top of Main Content
